ophthalmology

Zhaoke Ophthalmology’s Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children

indie 28 October

8 minutes

HONG KONG, Oct 28, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or “the Company”, SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research, […]

ACN Newswire

Zhaoke Ophthalmology Announces 2022 Interim Results

indie 24 August

15 minutes

HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”, SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research […]

ACN Newswire

Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002

indie 3 August

6 minutes

HONG KONG, Aug 3, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or “the Company”, SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research […]

ACN Newswire

Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002

indie 12 November

4 minutes

HONG KONG, Nov 12, 2020 – (ACN Newswire) – Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. (“Zhaoke Hong Kong”) is pleased to announce today that the first patient has completed three […]